Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions

NCT03129750 · clinicaltrials.gov ↗
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ettore Sansavini Health Science Foundation